Publications:

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research

Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER

Publication Date: 2023-03-16

Variant appearance in text: KCNH5: D304E

PubMed Link: 36928921

Variant Present in the following documents:

• ccr-22-3642_supplementary_tables_1_suppts1.xlsx, sheet 3

View BVdb publication page

External pH modulates EAG superfamily K+ channels through EAG-specific acidic residues in the voltage sensor.

The Journal Of General Physiology

Kazmierczak, Marcin M; Zhang, Xiaofei X; Chen, Bihan B; Mulkey, Daniel K DK; Shi, Yingtang Y; Wagner, Paul G PG; Pivaroff-Ward, Kendra K; Sassic, Jessica K JK; Bayliss, Douglas A DA; Jegla, Timothy T

Publication Date: 2013-06

Variant appearance in text: Kv10.2: D304E

PubMed Link: 23712551

Variant Present in the following documents:

• Main text
• JGP_201210938.pdf

View BVdb publication page